TRACON Pharmaceuticals/ US89237H3084 /
| 5/24/2024 8:41:22 PM | Chg. -0.05 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 1.50USD | -3.23% | 237 Turnover: 354.82 |
-Bid Size: - | -Ask Size: - | 1.50 | 1.50 |
GlobeNewswire
5/14
TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
5/7
TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
GlobeNewswire
4/3
TRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independe...
GlobeNewswire
3/5
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corpo...
GlobeNewswire
2/28
TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on ...
GlobeNewswire
12/20/2023
TRACON Pharmaceuticals Provides Positive Update on Ongoing ENVASARC Pivotal Phase 2 Trial
GlobeNewswire
11/20/2023
TRACON Pharmaceuticals Announces License of Product Development Platform for $3.0 Million Upfront Pa...
GlobeNewswire
11/9/2023
TRACON Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire
10/31/2023
TRACON to Report Third Quarter 2023 Financial Results and Provide Corporate Update on November 9, 20...
GlobeNewswire
9/18/2023
TRACON Pharmaceuticals Announces ENVASARC Phase 2 Pivotal Trial Exceeded Futility Threshold at Final...
GlobeNewswire
9/5/2023
TRACON Pharmaceuticals Announces Participation at Upcoming Investor Conferences
GlobeNewswire
3/28/2022
Saundra Pelletier, CEO of Evofem Biosciences, to Receive Honorary Degree from Husson University
GlobeNewswire
3/23/2022
TRACON Pharmaceuticals to Present at the Maxim Group 2022 Virtual Growth Conference
GlobeNewswire
3/15/2022
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corpo...
GlobeNewswire
3/11/2022
TRACON Pharmaceuticals to Present at the Oppenheimer 32nd Annual Healthcare Conference
GlobeNewswire
3/10/2022
Proactive news headlines including American Resources, HighGold Mining, Harbor Custom Development, F...
GlobeNewswire
3/4/2022
TRACON to Report Fourth Quarter and Full Year 2021 Financial Results and Corporate Update on March 1...
GlobeNewswire
2/23/2022
Proactive news headlines including TRACON Pharmaceuticals, Gratomic, Benchmark Metals, Potent Ventur...
GlobeNewswire
2/2/2022
TRACON Pharmaceuticals Announces Initiation of Randomized Phase 2 Trial of TRC102 in Lung Cancer Spo...
GlobeNewswire
1/5/2022
TRACON Pharmaceuticals to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
GlobeNewswire
12/27/2021
TRACON Pharmaceuticals Announces Positive Results from the Independent Data Monitoring Committee Rev...
